Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Prado

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Biomedical Materials (Bristol, England)|October 21, 2021
Biocide effect against SARS-CoV-2 and ESKAPE pathogens of a noncytotoxic silver-copper nanofilmJ M Bello-Lopez, P Silva-Bermudez, G Prado, et al.
Journal of Virology|May 20, 2016
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I AllelesCatherine K Koofhethile, Zaza M Ndhlovu, Christina Thobakgale-Tshabalala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2012
HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activationMaria T Rodriguez-Plata, Alejandra Urrutia, Sylvain Cardinaud, et al.
Elife|September 19, 2023
Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ARTOscar Blanch-Lombarte, Dan Ouchi, Esther Jimenez-Moyano, et al.
Journal of Virology|July 22, 2016
Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T CellsEsther Jimenez-Moyano, Alba Ruiz, Henrik N Kløverpris, et al.
Journal of Virology|August 6, 2010
Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cellsRebecca P Payne, Henrik Kløverpris, Jonah B Sacha, et al.
JMIR Public Health and Surveillance|December 9, 2024
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal StudyPere Torán-Monserrat, Noemí Lamonja-Vicente, Anna Costa-Garrido, et al.
Chemmedchem|August 11, 2025
Development of Dual Aurora-A and Aurora-B Degrading PROTACs for <i>MCYN</i>-Amplified NeuroblastomaSydney E Nelson, James R Tucker, Madelen G Prado, et al.
Journal of Virology|April 29, 2016
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationNicolas Noel, Ruth Peña, Annie David, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|April 16, 2014
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progressionJudith Dalmau, Margalida Rotger, Itziar Erkizia, et al.
Biomedical Materials (Bristol, England)|October 21, 2021
Biocide effect against SARS-CoV-2 and ESKAPE pathogens of a noncytotoxic silver-copper nanofilmJ M Bello-Lopez, P Silva-Bermudez, G Prado, et al.
Journal of Virology|May 20, 2016
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I AllelesCatherine K Koofhethile, Zaza M Ndhlovu, Christina Thobakgale-Tshabalala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2012
HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activationMaria T Rodriguez-Plata, Alejandra Urrutia, Sylvain Cardinaud, et al.
Elife|September 19, 2023
Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ARTOscar Blanch-Lombarte, Dan Ouchi, Esther Jimenez-Moyano, et al.
Journal of Virology|July 22, 2016
Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T CellsEsther Jimenez-Moyano, Alba Ruiz, Henrik N Kløverpris, et al.
Journal of Virology|August 6, 2010
Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cellsRebecca P Payne, Henrik Kløverpris, Jonah B Sacha, et al.
JMIR Public Health and Surveillance|December 9, 2024
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal StudyPere Torán-Monserrat, Noemí Lamonja-Vicente, Anna Costa-Garrido, et al.
Chemmedchem|August 11, 2025
Development of Dual Aurora-A and Aurora-B Degrading PROTACs for <i>MCYN</i>-Amplified NeuroblastomaSydney E Nelson, James R Tucker, Madelen G Prado, et al.
Journal of Virology|April 29, 2016
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationNicolas Noel, Ruth Peña, Annie David, et al.
Pageof 16